Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer
Nicole Williams(The Ohio State University), Robert Wesolowski(The Ohio State University Wexner Medical Center), Darlene M. Bystry(The Ohio State University), Adam Brufsky(University of Pittsburgh), Daniel G. Stover(Harvard University), Michael R. Grever(The Ohio State University Wexner Medical Center), Mara Chambers(University of Kentucky), Dionisia Quiroga(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), William E. Carson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sagar Sardesai(The Ohio State University Wexner Medical Center), Mitch A. Phelps(The Ohio State University), Bhuvaneswari Ramaswamy(The Ohio State University), Mathew Cherian(The Ohio State University Wexner Medical Center), Maryam B. Lustberg(Yale Cancer Center), Courtney Johnson(Clinton Foundation), Maria Patterson(The Ohio State University), Saveri Bhattacharya(University of Pennsylvania), Kasey Hill(The Ohio State University), Julie Stephens(The Ohio State University), Min Chen(Nanjing University of Chinese Medicine), Anne M. Noonan(The Ohio State University)
Cited by 14
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
|Journal of Clinical Oncology|1990|786